|
Opium derivatives and expectorants
|
R05FA |
|
|
combinations
|
G04BE30 |
|
|
beclometasone
|
R01AD01 |
|
|
Bioflavonoids
|
C05CA |
|
|
tiagabine
|
N03AG06 |
|
|
Sclerosing agents for local injection
|
C05BB |
|
|
progabide
|
N03AG05 |
|
|
valpromide
|
N03AG02 |
|
|
valproic acid
|
N03AG01 |
|
|
vigabatrin
|
N03AG04 |
|
|
aminobutyric acid
|
N03AG03 |
|
|
lansoprazole, tetracycline and metronidazole
|
A02BD02 |
|
|
omeprazole, amoxicillin and metronidazole
|
A02BD01 |
|
|
BLOOD AND RELATED PRODUCTS
|
B05A |
|
|
retigabine
|
N03AX21 |
|
|
I.V. SOLUTIONS
|
B05B |
|
|
IRRIGATING SOLUTIONS
|
B05C |
|
|
PERITONEAL DIALYTICS
|
B05D |
|
|
I.V. SOLUTION ADDITIVES
|
B05X |
|
|
lansoprazole, clarithromycin and tinidazole
|
A02BD09 |
|
